Tuesday, 07 October 2025
Clarivate Plc , a leading global provider of transformative intelligence, announced the incorporation of Pathway Maps in OFF-X, a cutting-edge translational safety intelligence solution. With over 30% of drug development failures attributed to safety issues1, preclinical and translational research teams face increasing pressure to identify potential liabilities earlier in the target selection pr
VUNO, a leading South Korean medical AI company, announced today that its flagship AI-powered cardiac arrest risk management system VUNO Med®-DeepCARS®(DeepCARS) has received CE MDR (Medical Device Regulation) certification in the European Union, as well as the UKCA (UK Conformity Assessed) mark in the United Kingdom. Achieving these regulatory milestones more than a year ahead of schedu
- Clarium, the company powering the world's first and market-leading AI-powered healthcare supply chain resiliency platform, announced a $27 million Series A funding round from Northzone, with participation from existing investors including General Catalyst, AlleyCorp, Kaiser Permanente Ventures, Texas Medical Center Ventures, and 1984 Ventures. This round brings Clarium's total funding to $43 m
European College of Sport and Exercise Physicians (ECOSEP) and Tata Elxsi have announced a strategic partnership that aims to revolutionise the field of sports and exercise medicine through combining the research excellence and clinical expertise of ECOSEP with Tata Elxsi's AI- and machine learning–driven healthcare solutions and technology capabilities. The partnership will focus on appl
Dawn Health and Merck have launched the next-generation digital ecosystem for growth disorders, designed to support patients with Growth Hormone Deficiency (GHD), their caregivers, and healthcare professionals (HCPs). This marks a step forward in digital solutions for GHD, enhancing accessibility, usability, and clinical support. Over the past year, Dawn Health and Merck have worked closely to ev
HistoIndex, known for its groundbreaking biophotonic Second Harmonic Generation (SHG) technology and a pioneering leader in Artificial Intelligence (AI) digital pathology for the management of fibrotic diseases, has announced the close of a S$9 million investment round to support its next phase of expansion. OCBC, the longest established bank in Singapore and the second largest financial service
Andor Health, the AI company reimagining virtual care with the #1 AI software infrastructure for healthcare, expands AI-first ThinkAndor® capabilities at Sentara Health. Sentara is among the top 20 largest not-for-profit integrated health systems in the country, with 34,000 employees, 12 hospitals in Virginia and Northeastern North Carolina, and the Sentara Health Plans division which serves
Andor Health, the AI company reimagining virtual care with the #1 AI software infrastructure for healthcare, expands AI-first ThinkAndor® capabilities at Sentara Health. Sentara is among the top 20 largest not-for-profit integrated health systems in the country, with 34,000 employees, 12 hospitals in Virginia and Northeastern North Carolina, and the Sentara Health Plans division which serves
As artificial intelligence rapidly transforms global industries, India’s KnowDis AI is charting a distinct path by fusing foundational research with real-world applications tailored to the country's needs. In this exclusive interview with AI Reporter Asia (AI Reporter America), Neeta Singal, Partner and Co-Founder of KnowDis AI, outlines the company’s ambitious 2025 inn
Blooming Health, a social care technology platform, announced it has raised $26 million in a Series A funding round led by global software investor Insight Partners, with participation from existing investors Afore Capital, Crossbeam Venture Partners, and Metrodora Ventures. This investment brings Blooming Health's total funding to $32.5 million. The round comes as Blooming Health accelera
Therapixel, the developer of MammoScreen, an AI-based breast cancer screening software, announces that Mayo Clinic has procured licenses for the use of MammoScreen across its radiology departments. The software provides radiologists with AI-generated insights to support the interpretation of screening mammograms. Therapixel previously participated in the MedTech Accelerator Program, a Mayo Clin
SimonMed Imaging®, one of the largest and most advanced outpatient medical imaging providers in the United States, is proud to announce their partnership with Lunit, a global leader in AI-driven cancer diagnostics and therapeutics, to bring a new era of AI-powered breast cancer detection to patients across the country. The partnership marks a major milestone in SimonMed's mission to save liv
Ascertain, a healthcare technology company empowering care teams with AI, announced $10 million in Series A funding in a financing round led by Deerfield Management with strategic participation from Northwell Health. The investment will accelerate the growth and expand access to Ascertain's AI-powered solutions to enable higher quality patient care, faster care journeys, and more cost-effi
At Reuters Events Pharma 2025 in Barcelona, industry leaders united to reimagine medical communications amidst content overload, AI adoption, and growing demand for personalized, compliant messaging at scale. In a powerful keynote, Dr. Namrata Singh, Founder & CEO of Turacoz Group, set a bold tone: "We are at the forefront of a content industrial revolution. To thrive, we must embrace
Biostate AI, a leading innovator in artificial intelligence for RNA sequencing,announced a strategic partnership with the Accelerated Cure Project (ACP), a nonprofit organization dedicated to accelerating research and improving outcomes for people with multiple sclerosis (MS). The partnership aims to develop next-generation AI models capable of predicting disease progression and treatment respon
- BCG X, the tech, build, and design division of Boston Consulting Group (BCG), announces the launch of its new AI Science Institute—leveraging BCG X's expertise and talent, supported by a 3000+ person team, including 200+ PhDs, to accelerate scientific discovery in collaboration with top R&D teams across leading industries and governments. BCG's strategic investment in artificial int
NEC Laboratories Europe and Data-Driven.AI are working together to enhance medical laboratory diagnosis and increase the effectiveness of preventive health measures and early clinical intervention to improve the well-being of patients. If detected early, many illnesses and diseases can be managed or resolved without serious complications. However, by the time recognizable symptoms present
Medical digital twins are virtual models of the human body that can help predict diseases with high accuracy. However, they are vulnerable to cyberattacks that can manipulate data and lead to incorrect diagnoses. To address this, researchers from Dongguk University developed the Wavelet-Based Adversarial Training (WBAD) defense system. Tested on a breast cancer diagnostic model, WBAD restor
Strategic Partnership Aims to Create Novel Drug Discovery Pipeline for Unmet Medical Needs by Combining PPI Control Technology with AI Drug Discovery Platform PRISM BioLab, Co. Ltd. ("PRISM BioLab"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered i
PCBAIR, a leading provider of PCB manufacturing and assembly services with fully automated production lines, announced that it is increasing funding for research and development to incorporate AI into its manufacturing processes, dramatically improving defect prediction accuracy and efficiency. "We are focused on improving our manufacturing processes," says Dr. Jian Li
Globant's strategic cooperation with Google Cloud delivers industry-specific solutions tailored to the needs of the Media & Entertainment, Retail, Healthcare, and Finance & Banking sectors. Globant (NYSE: GLOB), a digitally native company focused on reinventing businesses through innovative technology solutions, has announced a Strategic Partner Agreement w
Agilisium – a leading Data Innovation & Agentic AI partner for the Life Sciences industry, unveiled its domain-trained Insight Generation Agent, designed to unlock insight-led decisions across the spectrum of the life sciences value chain. This Insights Generation AI Agent is not a one-size-fits-all platform—it's a configurable intelligence layer purpose-built to address
By subscribing, you agree to receive email related to content and products. You unsubscribe at any time.
Copyright 2025, AI Reporter America All rights reserved.
